content

Part I of the CPHI Annual Report looks ahead at the potential for biologics outsourcing and contract manufacturing organisations (CMOs) in 2023 in advance...

According to a new report by IPPR, the UK's percentage of worldwide research and development (R&D) spending has decreased by 5% since 2014. Even...

Reacting rapidly after the initial onset of the pandemic the biopharma industry accelerated its research into advanced anti-viral modalities including messenger RNA (mRNA) vaccines....

The necessity to update and alter the FDA's now-contentious rapid approval strategy is highlighted by the protracted, complicated FDA process to discontinue commercialization of...

IFF's Pharma Solutions division—backed by 300 years of combined cellulosic excipient experience and housing leading brands like Avicel® and METHOCEL™, plus a robust seaweed-based...

Andelyn Biosciences, Inc., a world-leading gene therapy CDMO, announced the addition of a new GMP clinical and commercial manufacturing facility, the  Andelyn Corporate Center...

Prescriptions are quite expensive, and when you might need them to function at your best and to survive, it gets difficult to keep buying...